Examples of targeting moieties often exploited in nanomedicine are transferrin and folate, which target tumour cells overexpressing the corresponding receptors [23–24], or hyaluronic acid, which directs nanocarriers to CD44-overexpressing tumour cells [25], among many others. Here, CD44 is linked to neoplasm.